KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Assets (2009 - 2026)

Johnson & Johnson recorded quarterly Assets of $200.9 billion in Q1 2026, up 0.85% quarter-over-quarter from $199.2 billion in Q4 2025, and up 3.73% year-over-year from $193.7 billion in Q1 2025.

Johnson & Johnson's Assets history runs 18 years deep, the most recent figure standing at $200.9 billion for Q1 2026.

  • In Q1 2026, Assets rose 3.73% year-over-year to $200.9 billion; the TTM figure through Mar 2026 stood at $200.9 billion (up 3.73% YoY), while the FY2025 annual figure was $199.2 billion, up 10.61% from the prior year.
  • Assets came in at $200.9 billion for Q1 2026 at Johnson & Johnson, up from $199.2 billion in the prior quarter.
  • In the past five years, Assets ranged from a high of $200.9 billion in Q1 2026 to a low of $166.1 billion in Q4 2023.
  • A 5-year average of $184.1 billion and a median of $181.6 billion in 2022 frame the typical range for Assets.
  • Across the five-year window, Assets decreased 12.25% in 2024 and advanced 12.62% in 2025, its largest moves.
  • Johnson & Johnson's Assets stood at $175.1 billion in 2022, then decreased by 4.32% to $167.6 billion in 2023, then advanced by 7.49% to $180.1 billion in 2024, then advanced by 10.61% to $199.2 billion in 2025, then rose by 0.85% to $200.9 billion in 2026.
  • According to Business Quant data, Assets over the past three periods registered $200.9 billion, $199.2 billion, and $192.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 116.58 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 200.89 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 136.46 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 128.69 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 92.50 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 56.28 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 208.00 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 86.48 Bn
10 Gsk 88.34 Bn 83.66 Bn - 81.30 Bn

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 200.89 Bn
Dec 28, 2025 199.21 Bn
Sep 28, 2025 192.82 Bn
Jun 29, 2025 193.39 Bn
Mar 30, 2025 193.67 Bn
Dec 29, 2024 180.10 Bn
Sep 29, 2024 178.29 Bn
Jun 30, 2024 181.09 Bn
Mar 31, 2024 171.97 Bn
Dec 31, 2023 167.56 Bn
Oct 1, 2023 166.06 Bn
Jul 2, 2023 191.69 Bn
Apr 2, 2023 195.97 Bn
Jan 1, 2023 187.38 Bn
Oct 2, 2022 175.12 Bn
Jul 3, 2022 177.72 Bn
Apr 3, 2022 178.36 Bn
Jan 2, 2022 182.02 Bn
Oct 3, 2021 179.23 Bn
Jul 4, 2021 176.44 Bn
Apr 4, 2021 172.56 Bn
Jan 3, 2021 174.89 Bn
Sep 27, 2020 170.69 Bn
Jun 28, 2020 158.38 Bn
Mar 29, 2020 155.02 Bn
Dec 29, 2019 157.73 Bn
Sep 29, 2019 155.52 Bn
Jun 30, 2019 155.12 Bn
Mar 31, 2019 150.03 Bn
Dec 30, 2018 152.95 Bn
Sep 30, 2018 155.70 Bn
Jul 1, 2018 155.37 Bn
Apr 1, 2018 156.63 Bn
Dec 31, 2017 157.30 Bn
Oct 1, 2017 155.66 Bn
Jul 2, 2017 152.81 Bn
Apr 2, 2017 144.92 Bn
Jan 1, 2017 141.21 Bn
Oct 2, 2016 140.37 Bn
Jul 3, 2016 139.81 Bn
Apr 3, 2016 136.23 Bn
Jan 3, 2016 133.41 Bn
Sep 27, 2015 133.27 Bn
Jun 28, 2015 132.04 Bn
Mar 29, 2015 128.59 Bn
Dec 28, 2014 130.36 Bn
Sep 28, 2014 132.10 Bn
Jun 29, 2014 135.20 Bn
Mar 30, 2014 133.33 Bn
Dec 29, 2013 132.68 Bn
Sep 29, 2013 126.93 Bn
Jun 30, 2013 124.33 Bn
Mar 31, 2013 121.54 Bn
Dec 30, 2012 121.35 Bn
Sep 30, 2012 118.95 Bn
Jul 1, 2012 115.75 Bn
Apr 1, 2012 116.19 Bn
Jan 1, 2012 113.64 Bn
Oct 2, 2011 111.82 Bn
Jul 3, 2011 112.11 Bn
Apr 3, 2011 108.15 Bn
Jan 2, 2011 102.91 Bn
Oct 3, 2010 98.25 Bn
Jul 4, 2010 92.30 Bn
Apr 4, 2010 93.44 Bn
Jan 3, 2010 94.68 Bn
Sep 27, 2009 91.56 Bn
Jun 28, 2009 87.44 Bn